Elgodipine
Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris.
Product Specifications
CAS Number
119413-55-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
524.58
Molecular Formula
C29H33FN2O6
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
